Jim Schraidt Retiree Jim is recently retired after practicing real estate and commercial finance law for more than 40 years. He holds a BS in Finance from the University of Illinois at Urbana, and a JD from Southern Illinois University at Carbondale.After an ill-advised prostatectomy in 2010 at the age of 58, Jim developed treatment regret and a resulting clinical depression. He found help at an Us TOO support group in Chicago, and has been attending that group for over 11 years and leading it for nearly six years. He also leads a support group affiliated with Northwestern University in Chicago and is a moderator for the AnCan virtual support group focused on active surveillance. Prior to joining the ZERO Board of Directors upon the merger of Us TOO and ZERO, Jim was a member of the Us TOO Board for the past six years and served as the Chairman for two years.Jim is passionate about helping newly diagnosed prostate cancer patients get full and accurate information necessary to make the best possible treatment decision. He provides patients with support throughout the diagnosis and treatment and recovery process, and advocates for better and less harmful prostate cancer treatment.
Jim is recently retired after practicing real estate and commercial finance law for more than 40 years. He holds a BS in Finance from the University of Illinois at Urbana, and a JD from Southern Illinois University at Carbondale.After an ill-advised prostatectomy in 2010 at the age of 58, Jim developed treatment regret and a resulting clinical depression. He found help at an Us TOO support group in Chicago, and has been attending that group for over 11 years and leading it for nearly six years. He also leads a support group affiliated with Northwestern University in Chicago and is a moderator for the AnCan virtual support group focused on active surveillance. Prior to joining the ZERO Board of Directors upon the merger of Us TOO and ZERO, Jim was a member of the Us TOO Board for the past six years and served as the Chairman for two years.Jim is passionate about helping newly diagnosed prostate cancer patients get full and accurate information necessary to make the best possible treatment decision. He provides patients with support throughout the diagnosis and treatment and recovery process, and advocates for better and less harmful prostate cancer treatment.
